Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Vivaldi Coelho Rogerio Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 4 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 12,169 shares @ $0
Disposed/sold 35,382 options to buy @ $0.75, valued at $26.5k
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2023 4 Vivaldi Coelho Rogerio (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $22.06, valued at $110.3k
03/01/2023 4 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 460,000 options to buy @ $1.09, valued at $501.4k
06/21/2022 4 Vivaldi Coelho Rogerio (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Granted 8,750 options to buy @ $18.29, valued at $160k
04/04/2022 4/A Vivaldi Coelho Rogerio (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Granted 35,000 options to buy @ $28.31, valued at $990.9k
02/22/2022 4 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 230,000 options to buy @ $1.48, valued at $340.4k
01/10/2022 4 Vivaldi Coelho Rogerio (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $28.31, valued at $707.8k
01/10/2022 3 Vivaldi Coelho Rogerio (Director) has filed a Form 3 on Crinetics Pharmaceuticals, Inc.
01/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/05/2021 4 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 50,000 shares @ $0
02/16/2021 4 Vivaldi Coelho Rogerio (PRESIDENT AND CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 200,000 options to buy @ $39.81, valued at $8M
12/10/2020 4 Vivaldi Coelho Rogerio (President and CEO) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Converted 22,222 shares @ $0
Converted 22,222 convertible preferred @ $0
12/03/2020 3 Vivaldi Coelho Rogerio (President and CEO) has filed a Form 3 on Sigilon Therapeutics, Inc.
03/08/2018 4 Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 5,758 shares @ $0
Disposed/sold 14,230 restricted stock units @ $0
Disposed/sold 42,727 restricted stock units @ $0
Disposed/sold 113,230 options to buy @ $44.51, valued at $5M
Disposed/sold 56,615 options to buy @ $44.51, valued at $2.5M
02/15/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2018 4 Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) has filed a Form 4 on Bioverativ Inc.
Txns: Granted 42,727 restricted stock units @ $0
03/27/2017 4/A Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) has filed a Form 4 on Bioverativ Inc.
02/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/22/2016 3 Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) has filed a Form 3 on Bioverativ Inc.
07/19/2016 4 Vivaldi Coelho Rogerio (Chief Commercial Officer) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Sold 5,600 shares @ $52.96, valued at $296.6k
Sold 1,400 shares @ $53.32, valued at $74.6k
Exercised 1,000 options to buy @ $3.45, valued at $3.5k
Exercised 5,000 options to buy @ $7.5, valued at $37.5k
04/22/2016 4 Vivaldi Coelho Rogerio (Chief Commercial Officer) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Sold 5,800 shares @ $40.02, valued at $232.1k
Sold 1,200 shares @ $40.02, valued at $48k
Exercised 1,000 options to buy @ $3.45, valued at $3.5k
Exercised 4,800 options to buy @ $7.5, valued at $36k
Exercised 1,000 options to buy @ $3.45, valued at $3.5k
Exercised 200 options to buy @ $7.5, valued at $1.5k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy